How much does Daklinza cost?

The wholesale cost for a 12-week course of daclatasvir is roughly $63,000, but patients may be responsible to pay a range of $72,000 to $75,000. Insurance may pay for this medication. The manufacturer, Bristol-Myers Squibb, may be able to offer financial assistance with medication access for patients who qualify.Patients may call 844-442-6663 to speak with a representative.

Daklinza (generic name: daclatasvir) is approved for the treatment of genotype 3 chronic hepatitis C virus (HCV) with sofosbuvir (brand name: Sovaldi) in adults, and in combination with sofosbuvir (with or without ribavirin) in genotypes 1 and 3, including hard to treat HCV patients such as those with HIV-1 coinfection, advanced cirrhosis, or post-liver transplant recurrence of HCV.